UBS Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $89.5M | Buy |
|
|||||
|
2025
Q2 | $56M | Sell |
|
|||||
|
2025
Q1 | $88.4M | Sell |
|
|||||
|
2024
Q4 | $160M | Buy |
|
|||||
|
2024
Q3 | $97.7M | Buy |
|
|||||
|
2024
Q2 | $105M | Sell |
|
|||||
|
2024
Q1 | $103M | Buy |
|
|||||
|
2023
Q4 | $87.6M | Sell |
|
|||||
|
2023
Q3 | $108M | Buy |
|
|||||
|
2023
Q2 | $112M | Buy |
|
|||||
|
2023
Q1 | $82.3M | Buy |
|
|||||
|
2022
Q4 | $81.5M | Buy |
|
|||||
|
2022
Q3 | $39.2M | Sell |
|
|||||
|
2022
Q2 | $57M | Sell |
|
|||||
|
2022
Q1 | $76.6M | Buy |
|
|||||
|
2021
Q4 | $86.9M | Buy |
|
|||||
|
2021
Q3 | $88.8M | Buy |
|
|||||
|
2021
Q2 | $82.8M | Buy |
|
|||||
|
2021
Q1 | $55.7M | Sell |
|
|||||
|
2020
Q4 | $57.1M | Buy |
|
|||||
|
2020
Q3 | $38.4M | Sell |
|
|||||
|
2020
Q2 | $84.5M | Buy |
|
|||||
|
2020
Q1 | $83.4M | Sell |
|
|||||
|
2019
Q4 | $80.1M | Sell |
|
|||||
|
2019
Q3 | $90.4M | Buy |
|
|||||
|
2019
Q2 | $78.4M | Sell |
|
|||||
|
2019
Q1 | $82.8M | Buy |
|
|||||
|
2018
Q4 | $60.5M | Sell |
|
|||||
|
2018
Q3 | $131M | Buy |
|
|||||
|
2018
Q2 | $93.1M | Sell |
|
|||||
|
2018
Q1 | $97.8M | Sell |
|
|||||
|
2017
Q4 | $141M | Buy |
|
|||||
|
2017
Q3 | $62.5M | Sell |
|
|||||
|
2017
Q2 | $77.7M | Buy |
|
|||||
|
2017
Q1 | $47.9M | Buy |
|
|||||
|
2016
Q4 | $49.4M | Sell |
|
|||||
|
2016
Q3 | $99.1M | Buy |
|
|||||
|
2016
Q2 | $62.6M | Buy |
|
|||||
|
2016
Q1 | $65M | Sell |
|
|||||
|
2015
Q4 | $149M | Buy |
|
|||||
|
2015
Q3 | $58.4M | Buy |
|
|||||
|
2015
Q2 | $57.8M | Buy |
|
|||||
|
2015
Q1 | $58.8M | Sell |
|
|||||
|
2014
Q4 | $50.6M | Buy |
|